Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
11.76
Dollar change
+0.30
Percentage change
2.62
%
IndexRUT P/E- EPS (ttm)-1.80 Insider Own7.51% Shs Outstand53.52M Perf Week23.01%
Market Cap629.38M Forward P/E- EPS next Y-3.19 Insider Trans26.36% Shs Float49.50M Perf Month43.24%
Income-86.82M PEG- EPS next Q-0.56 Inst Own103.53% Short Float18.53% Perf Quarter34.40%
Sales50.39M P/S12.49 EPS this Y-29.89% Inst Trans10.32% Short Ratio12.68 Perf Half Y-41.02%
Book/sh4.38 P/B2.69 EPS next Y-34.78% ROA-34.74% Short Interest9.17M Perf Year95.35%
Cash/sh5.24 P/C2.25 EPS next 5Y- ROE-60.81% 52W Range5.74 - 30.99 Perf YTD-49.11%
Dividend Est.- P/FCF- EPS past 5Y29.57% ROI-34.66% 52W High-62.05% Beta1.57
Dividend TTM- Quick Ratio4.69 Sales past 5Y69.47% Gross Margin91.35% 52W Low104.88% ATR (14)1.02
Dividend Ex-Date- Current Ratio4.75 EPS Y/Y TTM36.56% Oper. Margin-195.71% RSI (14)64.33 Volatility15.85% 9.31%
Employees121 Debt/Eq0.10 Sales Y/Y TTM34.98% Profit Margin-172.29% Recom1.15 Target Price36.08
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q5.02% Payout- Rel Volume1.99 Prev Close11.46
Sales Surprise-10.66% EPS Surprise-14.97% Sales Q/Q4.09% EarningsAug 07 BMO Avg Volume723.19K Price11.76
SMA2016.34% SMA5028.31% SMA200-20.10% Trades Volume1,436,254 Change2.62%
Date Action Analyst Rating Change Price Target Change
Oct-16-24Initiated Scotiabank Sector Outperform
Aug-28-24Initiated Jefferies Buy $15
Jan-22-24Initiated JP Morgan Overweight $35
Nov-02-23Initiated Mizuho Buy $20
Apr-21-23Initiated Robert W. Baird Outperform $33
Jul-07-22Initiated Chardan Capital Markets Buy $21
Mar-01-21Initiated Cowen Outperform $25
Jan-28-21Initiated Cantor Fitzgerald Overweight $22
Apr-06-20Downgrade B. Riley FBR Buy → Neutral $4 → $1
Nov-04-19Resumed Laidlaw Buy $5
Today 04:00PM
Oct-29-24 09:47PM
04:49AM
Oct-28-24 05:14PM
12:16PM
07:00AM Loading…
07:00AM
Oct-24-24 07:00AM
Oct-23-24 09:20AM
Oct-16-24 07:00AM
Sep-16-24 07:00AM
Sep-04-24 07:00AM
Aug-27-24 07:00AM
Aug-16-24 07:00AM
Aug-08-24 07:00AM
Aug-07-24 08:15AM
07:09AM Loading…
07:09AM
07:00AM
Jul-16-24 07:00AM
Jul-15-24 08:00AM
Jun-26-24 08:00AM
08:00AM
Jun-18-24 07:00AM
Jun-17-24 07:00AM
Jun-05-24 07:00AM
02:35AM
May-17-24 02:34AM
May-16-24 07:00AM
May-10-24 02:34PM
May-08-24 01:54PM
10:48AM
07:23AM Loading…
07:23AM
07:00AM
May-07-24 09:32AM
May-06-24 11:00AM
08:42AM
07:00AM
Apr-23-24 01:21PM
Apr-16-24 07:00AM
Apr-02-24 07:00AM
Mar-18-24 07:00AM
Mar-15-24 01:00PM
Mar-08-24 09:31AM
Mar-07-24 09:39PM
01:25PM
12:53PM
09:30AM
07:20AM
07:00AM
Mar-04-24 07:00AM
Feb-29-24 10:00AM
08:50AM
07:00AM
04:19AM
Feb-27-24 07:00AM
Feb-16-24 07:00AM
Feb-15-24 12:00PM
Feb-13-24 09:55AM
08:50AM
Feb-03-24 04:20PM
Jan-31-24 07:00AM
Jan-29-24 11:02PM
Jan-25-24 11:51PM
Jan-24-24 07:01PM
Jan-16-24 07:00AM
Jan-11-24 07:14PM
Jan-10-24 07:00AM
Dec-20-23 07:00AM
Dec-18-23 07:00AM
Dec-13-23 12:45PM
Dec-11-23 12:00PM
Dec-08-23 04:01PM
09:55AM
08:50AM
Dec-07-23 01:07PM
Dec-05-23 08:18PM
09:18AM
Dec-04-23 04:06PM
11:37AM
07:00AM
06:19AM
Nov-21-23 09:55AM
Nov-16-23 07:00AM
Nov-02-23 07:04PM
Nov-01-23 09:33AM
07:06AM
07:00AM
Oct-31-23 07:00AM
Oct-30-23 07:00AM
Oct-25-23 07:00AM
Oct-16-23 07:00AM
Sep-18-23 07:00AM
Sep-11-23 03:20PM
07:00AM
Aug-30-23 07:00AM
Aug-23-23 07:34PM
Aug-16-23 07:00AM
Aug-09-23 07:00AM
Aug-02-23 08:35AM
07:30AM
07:00AM
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANTHONY P. ADAMISDirectorOct 23 '24Proposed Sale10.0467,100673,355Oct 23 04:34 PM
David R. GuyerFormer DirectorOct 14 '24Proposed Sale8.9236,975329,817Oct 15 11:58 AM
DICICCO WENDY FDirectorAug 20 '24Buy7.792,56719,9979,967Aug 21 04:32 PM
ANDO GORANDirectorAug 21 '24Buy7.955,00039,75013,150Aug 21 04:01 PM
Zaderej Karen L.DirectorAug 19 '24Buy7.9812,50099,75016,500Aug 21 04:01 PM
Lurker NancyDirectorAug 16 '24Buy7.883,17325,00397,635Aug 20 04:04 PM
GUYER DAVID RDirectorJul 12 '24Option Exercise3.349,77532,64613,475Jul 16 04:24 PM
GUYER DAVID RDirectorJul 12 '24Sale10.0611,625116,9951,850Jul 16 04:24 PM
Duker Jay S.President and CEOJul 10 '24Option Exercise0.0016,666046,086Jul 12 05:04 PM
Lurker NancyExecutive Vice ChairJul 10 '24Option Exercise0.0011,111094,462Jul 12 05:03 PM
Zaderej Karen L.DirectorJul 11 '24Option Exercise0.002,00004,000Jul 12 05:00 PM
ADAMIS ANTHONY PDirectorJun 23 '24Option Exercise0.002,00004,000Jun 25 04:16 PM
GUYER DAVID RDirectorJun 03 '24Option Exercise3.349,77532,64615,325Jun 04 04:28 PM
GUYER DAVID RDirectorJun 03 '24Sale10.3011,625119,7053,700Jun 04 04:28 PM
Elston GeorgeChief Financial OfficerMay 25 '24Option Exercise0.007,500051,107May 28 04:22 PM
GUYER DAVID RDirectorMay 14 '24Option Exercise3.349,77532,64617,175May 16 05:19 PM
GUYER DAVID RDirectorMay 14 '24Sale12.6511,625147,0455,550May 16 05:19 PM
Cormorant Asset Management, LP10% OwnerMay 06 '24Buy11.86850,00010,081,7218,325,000May 08 04:23 PM
Cormorant Asset Management, LP10% OwnerApr 18 '24Buy18.03581,76510,489,4467,475,000Apr 22 04:00 PM
Paggiarino Dario A.Chief Medical OfficerMar 30 '24Option Exercise0.0050,404092,626Apr 02 05:27 PM
Lurker NancyExecutive Vice ChairFeb 09 '24Option Exercise0.0037,5340172,975Feb 13 05:40 PM
Paggiarino Dario A.Chief Medical OfficerFeb 09 '24Option Exercise0.0010,800047,305Feb 13 05:39 PM
Jones David ScottSVP & Chief Commercial OfficerFeb 09 '24Option Exercise0.009,967048,572Feb 13 05:38 PM
Elston GeorgeChief Financial OfficerFeb 09 '24Option Exercise0.0010,800046,799Feb 13 05:38 PM
Duker Jay S.President and CEOFeb 09 '24Option Exercise0.0011,967055,453Feb 13 05:37 PM
Jones David ScottSVP & Chief Commercial OfficerFeb 02 '24Option Exercise11.472092,39738,171Feb 05 05:15 PM
Jones David ScottSVP & Chief Commercial OfficerFeb 02 '24Sale28.492095,95437,962Feb 05 05:15 PM
Paggiarino Dario A.Chief Medical OfficerJan 26 '24Option Exercise13.0649,325644,04785,830Jan 30 04:53 PM
Paggiarino Dario A.Chief Medical OfficerJan 26 '24Sale25.6649,3251,265,53936,505Jan 30 04:53 PM
Jones David ScottSVP & Chief Commercial OfficerJan 26 '24Option Exercise6.8226,017177,39863,979Jan 29 05:54 PM
Jones David ScottSVP & Chief Commercial OfficerJan 26 '24Sale25.3826,017660,37037,962Jan 29 05:54 PM
Paggiarino Dario A.Chief Medical OfficerJan 25 '24Option Exercise13.026007,80937,105Jan 29 05:51 PM
Paggiarino Dario A.Chief Medical OfficerJan 25 '24Sale25.0060015,00036,505Jan 29 05:51 PM
Jones David ScottSVP & Chief Commercial OfficerJan 24 '24Option Exercise8.0411,30090,82249,262Jan 26 05:03 PM
Jones David ScottSVP & Chief Commercial OfficerJan 25 '24Option Exercise8.086004,84838,562Jan 26 05:03 PM
Jones David ScottSVP & Chief Commercial OfficerJan 24 '24Sale25.0111,300282,62137,962Jan 26 05:03 PM
Jones David ScottSVP & Chief Commercial OfficerJan 25 '24Sale25.0060015,00037,962Jan 26 05:03 PM
Paggiarino Dario A.Chief Medical OfficerJan 24 '24Option Exercise13.0111,251146,42647,756Jan 25 06:26 PM
Paggiarino Dario A.Chief Medical OfficerJan 23 '24Option Exercise13.045,13566,95441,640Jan 25 06:26 PM
Paggiarino Dario A.Chief Medical OfficerJan 24 '24Sale25.0111,251281,41536,505Jan 25 06:26 PM
Paggiarino Dario A.Chief Medical OfficerJan 23 '24Sale25.005,135128,37536,505Jan 25 06:26 PM
Lurker NancyExecutive Vice ChairJan 24 '24Sale24.9829,956748,250135,441Jan 25 06:24 PM
Lurker NancyExecutive Vice ChairJan 23 '24Sale24.975,044125,950165,397Jan 25 06:24 PM
Jones David ScottSVP & Chief Commercial OfficerJan 22 '24Option Exercise10.3434,166353,35972,128Jan 24 04:50 PM
Jones David ScottSVP & Chief Commercial OfficerJan 23 '24Option Exercise7.549006,79038,862Jan 24 04:50 PM
Jones David ScottSVP & Chief Commercial OfficerJan 22 '24Sale22.6234,166772,69137,962Jan 24 04:50 PM
Jones David ScottSVP & Chief Commercial OfficerJan 23 '24Sale25.0090022,50037,962Jan 24 04:50 PM
Ocumension TherapeuticsDirectorJan 11 '24Sale19.451,910,50037,159,225100,221Jan 16 06:55 PM
Liu YeDirectorJan 11 '24Sale19.451,910,50037,159,225100,221Jan 16 06:01 PM
Cormorant Asset Management, LP10% OwnerJan 11 '24Buy19.75750,00014,812,5006,893,235Jan 11 04:00 PM
Cormorant Asset Management, LP10% OwnerJan 09 '24Buy21.32105,0002,238,6006,143,235Jan 11 04:00 PM
Paggiarino Dario A.Chief Medical OfficerJan 08 '24Option Exercise3.2622,91374,69659,418Jan 10 04:53 PM
Paggiarino Dario A.Chief Medical OfficerJan 08 '24Sale21.1322,913484,12436,505Jan 10 04:53 PM
Paggiarino Dario A.Chief Medical OfficerJan 06 '24Option Exercise0.0015,285040,992Jan 09 09:28 PM
Lurker NancyExecutive Vice ChairJan 06 '24Option Exercise0.0075,1330193,484Jan 09 09:17 PM
Pine Michael CraigChief Corp Dev.&Strat. OfficerJan 06 '24Option Exercise0.0015,285019,628Jan 09 09:11 PM
Jones David ScottSVP & Chief Commercial OfficerJan 06 '24Option Exercise0.0015,285042,109Jan 09 09:09 PM
Duker Jay S.President and CEOJan 06 '24Option Exercise0.0020,793050,014Jan 09 09:07 PM
Elston GeorgeChief Financial OfficerJan 06 '24Option Exercise0.0015,285040,219Jan 09 09:04 PM
Paggiarino Dario A.Chief Medical OfficerDec 13 '23Option Exercise10.131,45814,77027,165Dec 15 05:14 PM
Paggiarino Dario A.Chief Medical OfficerDec 13 '23Sale20.001,45829,16025,707Dec 15 05:14 PM
Cormorant Asset Management, LP10% OwnerDec 08 '23Buy17.00588,2359,999,9956,038,235Dec 12 04:52 PM
Ocumension TherapeuticsDirectorDec 05 '23Sale19.91733,75814,609,1222,276,963Dec 07 09:21 PM
Ocumension TherapeuticsDirectorDec 06 '23Sale18.41266,2424,901,5152,010,721Dec 07 09:21 PM
Liu YeDirectorDec 05 '23Sale19.91733,75814,609,1222,276,963Dec 07 09:03 PM
Liu YeDirectorDec 06 '23Sale18.41266,2424,901,5152,010,721Dec 07 09:03 PM
Pine Michael CraigChief Corp Dev.&Strat. OfficerDec 04 '23Option Exercise12.6245,000567,90050,343Dec 06 05:20 PM
Pine Michael CraigChief Corp Dev.&Strat. OfficerDec 04 '23Sale22.0045,000990,0005,343Dec 06 05:20 PM
Paggiarino Dario A.Chief Medical OfficerDec 04 '23Option Exercise10.1330,625310,23156,332Dec 06 05:19 PM
Paggiarino Dario A.Chief Medical OfficerDec 04 '23Sale22.0030,625673,75025,707Dec 06 05:19 PM
Lurker NancyExecutive Vice ChairDec 04 '23Sale20.7620,000415,200170,559Dec 06 05:18 PM
Cormorant Asset Management, LP10% OwnerDec 04 '23Buy21.821,919,05741,874,1515,450,000Dec 06 04:39 PM